Rayont Inc. (RAYT) Stock
Rayont Inc., primarily operating through its subsidiary THF Holdings Pty Ltd., specializes in the development of medical devices and cancer treatments. Established in 2011, the company maintains its headquarters in Southport, Australia, and was formerly recognized as Velt International Group Inc.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Rayont Inc.
Rayont Inc., primarily operating through its subsidiary THF Holdings Pty Ltd., specializes in the development of medical devices and cancer treatments. Established in 2011, the company maintains its headquarters in Southport, Australia, and was formerly recognized as Velt International Group Inc.
Rayont Inc. is headquartered in AU.
Rayont Inc. (RAYT) stock trades at $0.03 with a market capitalization of $1.46M. The stock is valued at a price-to-earnings (P/E) ratio of 2.91, price-to-book of 0.27, price-to-sales of 0.51. Over the past 52 weeks the stock has ranged between $0.03 and $0.10, and currently trades 70.0% below its 52-week high.
On profitability, Rayont Inc. generates a return on equity (ROE) of 8.14%, return on capital employed of 8.57%, an operating margin of 31.15%, a net profit margin of 8.62%.
Official website: rayont.com